All In MedTech

FDA Clearance Tracker · P160028

Philips HeartStart FR3 Defibrillator

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: May 11, 2020 (this decision)Source: openFDAMethods & limitations

PMA

Decided

May 11, 2020

Approved

Time to decision

1,382 days

Received Jul 29, 2016. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P160028
Device name
Philips HeartStart FR3 Defibrillator
Applicant location
Bothell, WA
Received
Jul 29, 2016
Decided
May 11, 2020
Decision
Approved
Supplements
7 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III
Regulation
21 CFR 870.5310

Every decision under product code MKJ

FDA's approval statement

As written in FDA's record.

Approval for the Philips HeartStart FR3 Defibrillator. The models 861388 and 861389 are indicated for use by trained responders to treat ventricular fibrillation (VF), the most common cause of sudden cardiac arrest (SCA), and pulseless ventricular tachycardias (VTs). The models 861388 and 861389 are used with the SmartPads III or DP defibrillator pads applied to potential victims of SCA with the following symptoms: 1) Unresponsiveness;2) Absence of normal breathing; and3) Absence of pulse or signs of circulationThe models 861388 and 861389 are intended for adults and children over 55 pounds (25 kg) or greater than 8 years old. The models 861388 and 861389 are also intended for children under 55 pounds (25 kg) or 0-8 years old when used with the optional Infant/Child Key. If the Infant/Child Key is not available, or you are uncertain of the child’s age or weight, do not delay treatment.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code MKJ. The earliest in FDA's data is K853564, decided Oct 11, 1985.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Philips Medical Systems, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.